Are there any clinical studies that track lurbinectedin safety in pregnant people?
No human pregnancy-specific safety study results for lurbinectedin are provided in the available material here. The provided information only indicates that lurbinectedin can cause fetal harm and that pregnancy should be avoided during treatment, but it does not list any studies that enroll pregnant patients or systematically report outcomes by gestational age.
What does the available data say about pregnancy risk with lurbinectedin?
The available labeling information states that lurbinectedin can cause fetal harm. It also advises using effective contraception during treatment and for a defined period after the last dose. It additionally instructs patients to contact a healthcare provider if they become pregnant.
Is there any information from animal studies?
The available material does not include any animal-study findings on reproduction or fetal toxicity for lurbinectedin in the excerpt provided. That means there’s not enough here to confirm whether nonclinical reproductive studies were performed or what they found.
If I’m pregnant or planning pregnancy, what guidance is typically given?
Based on the pregnancy risk statement in the available material, the expectation is that clinicians treat lurbinectedin as unsafe for pregnancy and recommend contraception to prevent exposure. If pregnancy occurs, the guidance is to seek medical advice promptly.
What would be the best place to look for pregnancy safety evidence?
Pregnancy safety evidence usually appears in one of these places:
- the full prescribing information (including “Pregnancy,” “Lactation,” and “Teratogenicity” sections),
- pregnancy registries or post-marketing safety reports,
- clinical trial records or publications that mention inadvertent pregnancy exposure.
If you share the exact source you’re using (for example, the lurbinectedin prescribing information link or a trial name), I can help locate whether any pregnancy exposure reports or registry data are included.
Bottom line
From the information available here, there are no specific studies reported that evaluate lurbinectedin’s safety during pregnancy in humans. The material instead flags fetal harm risk and directs patients to avoid pregnancy during treatment.
Sources:
1. https://www.accessdata.fda.gov/ (lurbinectedin prescribing information/patient safety sections, as referenced in the provided materials)